Details for New Drug Application (NDA): 212983
✉ Email this page to a colleague
The generic ingredient in NICOTINE POLACRILEX is nicotine polacrilex. There are thirty drug master file entries for this compound. Sixty suppliers are listed for this compound. Additional details are available on the nicotine polacrilex profile page.
Summary for 212983
Tradename: | NICOTINE POLACRILEX |
Applicant: | Dr Reddys Labs Sa |
Ingredient: | nicotine polacrilex |
Patents: | 0 |
Suppliers and Packaging for NDA: 212983
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NICOTINE POLACRILEX | nicotine polacrilex | TROCHE/LOZENGE;ORAL | 212983 | ANDA | Dr. Reddy's Laboratories Inc. | 43598-484 | 43598-484-10 | 4 BOTTLE in 1 CARTON (43598-484-10) / 27 LOZENGE in 1 BOTTLE |
NICOTINE POLACRILEX | nicotine polacrilex | TROCHE/LOZENGE;ORAL | 212983 | ANDA | Dr. Reddy's Laboratories Inc. | 43598-484 | 43598-484-12 | 5 BOTTLE in 1 CARTON (43598-484-12) / 24 LOZENGE in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | TROCHE/LOZENGE;ORAL | Strength | EQ 2MG BASE | ||||
Approval Date: | Feb 21, 2020 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | OTC | Dosage: | TROCHE/LOZENGE;ORAL | Strength | EQ 4MG BASE | ||||
Approval Date: | Feb 21, 2020 | TE: | RLD: | No |
Complete Access Available with Subscription